
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion
Linda Ziani, Thouraya Ben Safta-Saadoun, Johanne Gourbeix, et al.
Oncotarget (2017) Vol. 8, Iss. 12, pp. 19780-19794
Open Access | Times Cited: 110
Linda Ziani, Thouraya Ben Safta-Saadoun, Johanne Gourbeix, et al.
Oncotarget (2017) Vol. 8, Iss. 12, pp. 19780-19794
Open Access | Times Cited: 110
Showing 1-25 of 110 citing articles:
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
Xiaoqi Mao, Jin Xu, Wei Wang, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 1426
Xiaoqi Mao, Jin Xu, Wei Wang, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 1426
The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment
Lea Monteran, Neta Erez
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 556
Lea Monteran, Neta Erez
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 556
In search of definitions: Cancer‐associated fibroblasts and their markers
Martin Nurmik, Pit Ullmann, Fabien Rodriguez, et al.
International Journal of Cancer (2019) Vol. 146, Iss. 4, pp. 895-905
Open Access | Times Cited: 552
Martin Nurmik, Pit Ullmann, Fabien Rodriguez, et al.
International Journal of Cancer (2019) Vol. 146, Iss. 4, pp. 895-905
Open Access | Times Cited: 552
Alteration of the Antitumor Immune Response by Cancer-Associated Fibroblasts
Linda Ziani, Salem Chouaı̈b, Jérôme Thiery
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 322
Linda Ziani, Salem Chouaı̈b, Jérôme Thiery
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 322
Cancer-associated fibroblasts in tumor microenvironment – Accomplices in tumor malignancy
Zehuan Liao, Zhen Tan, Pengcheng Zhu, et al.
Cellular Immunology (2018) Vol. 343, pp. 103729-103729
Open Access | Times Cited: 296
Zehuan Liao, Zhen Tan, Pengcheng Zhu, et al.
Cellular Immunology (2018) Vol. 343, pp. 103729-103729
Open Access | Times Cited: 296
Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment
Monica Marzagalli, Nancy D. Ebelt, Edwin R. Manuel
Seminars in Cancer Biology (2019) Vol. 59, pp. 236-250
Open Access | Times Cited: 275
Monica Marzagalli, Nancy D. Ebelt, Edwin R. Manuel
Seminars in Cancer Biology (2019) Vol. 59, pp. 236-250
Open Access | Times Cited: 275
Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy
Richard Lee Barrett, Ellen Puré
eLife (2020) Vol. 9
Open Access | Times Cited: 250
Richard Lee Barrett, Ellen Puré
eLife (2020) Vol. 9
Open Access | Times Cited: 250
Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies
Rana Mhaidly, Fatima Mechta‐Grigoriou
Seminars in Immunology (2020) Vol. 48, pp. 101417-101417
Open Access | Times Cited: 205
Rana Mhaidly, Fatima Mechta‐Grigoriou
Seminars in Immunology (2020) Vol. 48, pp. 101417-101417
Open Access | Times Cited: 205
Fibroblasts in cancer: Unity in heterogeneity
Yash Chhabra, Ashani T. Weeraratna
Cell (2023) Vol. 186, Iss. 8, pp. 1580-1609
Closed Access | Times Cited: 199
Yash Chhabra, Ashani T. Weeraratna
Cell (2023) Vol. 186, Iss. 8, pp. 1580-1609
Closed Access | Times Cited: 199
The Role of Cancer-Associated Fibroblasts in Cancer Invasion and Metastasis
Paris Jabeen Asif, Ciro Longobardi, Michael Hahne, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4720-4720
Open Access | Times Cited: 175
Paris Jabeen Asif, Ciro Longobardi, Michael Hahne, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4720-4720
Open Access | Times Cited: 175
Mechanisms of immune activation and regulation: lessons from melanoma
Shelly Kalaora, Adi Nagler, Jennifer A. Wargo, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 4, pp. 195-207
Closed Access | Times Cited: 170
Shelly Kalaora, Adi Nagler, Jennifer A. Wargo, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 4, pp. 195-207
Closed Access | Times Cited: 170
RETRACTED: Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92/PD-L1 Pathway
Dongwei Dou, Xiaoyang Ren, Mingli Han, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 159
Dongwei Dou, Xiaoyang Ren, Mingli Han, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 159
Targeting CAFs to overcome anticancer therapeutic resistance
Phei Er Saw, Jianing Chen, Erwei Song
Trends in cancer (2022) Vol. 8, Iss. 7, pp. 527-555
Closed Access | Times Cited: 127
Phei Er Saw, Jianing Chen, Erwei Song
Trends in cancer (2022) Vol. 8, Iss. 7, pp. 527-555
Closed Access | Times Cited: 127
NK cells and solid tumors: therapeutic potential and persisting obstacles
Le Tong, Carlos Jiménez‐Cortegana, Apple H.M. Tay, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 100
Le Tong, Carlos Jiménez‐Cortegana, Apple H.M. Tay, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 100
CAFs orchestrates tumor immune microenvironment—A new target in cancer therapy?
Chunxue Zhang, Yuxiang Fei, Hui Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 58
Chunxue Zhang, Yuxiang Fei, Hui Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 58
From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts
Ludovica Arpinati, Ruth Scherz‐Shouval
Trends in cancer (2023) Vol. 9, Iss. 5, pp. 421-443
Closed Access | Times Cited: 50
Ludovica Arpinati, Ruth Scherz‐Shouval
Trends in cancer (2023) Vol. 9, Iss. 5, pp. 421-443
Closed Access | Times Cited: 50
Cancer-associated fibroblasts impair the cytotoxic function of NK cells in gastric cancer by inducing ferroptosis via iron regulation
Lizhong Yao, Junyi Hou, Xiongyan Wu, et al.
Redox Biology (2023) Vol. 67, pp. 102923-102923
Open Access | Times Cited: 48
Lizhong Yao, Junyi Hou, Xiongyan Wu, et al.
Redox Biology (2023) Vol. 67, pp. 102923-102923
Open Access | Times Cited: 48
Investigating the Dynamic Interplay Between Cellular Immunity and Tumor Cells in the Fight Against Cancer: An Updated Comprehensive Review
Seyed Ali Aghapour, Mehdi Torabizadeh, Seyed Sobhan Bahreiny, et al.
Iranian Journal of Blood and Cancer (2024) Vol. 16, Iss. 2, pp. 84-101
Closed Access | Times Cited: 34
Seyed Ali Aghapour, Mehdi Torabizadeh, Seyed Sobhan Bahreiny, et al.
Iranian Journal of Blood and Cancer (2024) Vol. 16, Iss. 2, pp. 84-101
Closed Access | Times Cited: 34
Modelling the complex nature of the tumor microenvironment: 3D tumor spheroids as an evolving tool
Daniel B. Rodrigues, Rui L. Reis, Rogério P. Pirraco
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 17
Daniel B. Rodrigues, Rui L. Reis, Rogério P. Pirraco
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 17
The role of laminins in cancer pathobiology: a comprehensive review
Elena Nonnast, E. Mira, Santos Mañes
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Elena Nonnast, E. Mira, Santos Mañes
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Natural Killer Cells as Key Players of Tumor Progression and Angiogenesis: Old and Novel Tools to Divert Their Pro-Tumor Activities into Potent Anti-Tumor Effects
Barbara Bassani, Denisa Baci, Matteo Gallazzi, et al.
Cancers (2019) Vol. 11, Iss. 4, pp. 461-461
Open Access | Times Cited: 142
Barbara Bassani, Denisa Baci, Matteo Gallazzi, et al.
Cancers (2019) Vol. 11, Iss. 4, pp. 461-461
Open Access | Times Cited: 142
Fibroblasts Fuel Immune Escape in the Tumor Microenvironment
Emiel A. De Jaeghere, Hannelore Denys, Olivier De Wever
Trends in cancer (2019) Vol. 5, Iss. 11, pp. 704-723
Closed Access | Times Cited: 134
Emiel A. De Jaeghere, Hannelore Denys, Olivier De Wever
Trends in cancer (2019) Vol. 5, Iss. 11, pp. 704-723
Closed Access | Times Cited: 134
The Influence of Tumor Microenvironment on Immune Escape of Melanoma
Aleksandra Simiczyjew, Ewelina Dratkiewicz, Justyna Mazurkiewicz, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8359-8359
Open Access | Times Cited: 110
Aleksandra Simiczyjew, Ewelina Dratkiewicz, Justyna Mazurkiewicz, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8359-8359
Open Access | Times Cited: 110
Management and potentialities of primary cancer cultures in preclinical and translational studies
Giacomo Miserocchi, Laura Mercatali, Chiara Liverani, et al.
Journal of Translational Medicine (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 103
Giacomo Miserocchi, Laura Mercatali, Chiara Liverani, et al.
Journal of Translational Medicine (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 103
Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy
Italia Falcone, Fabiana Conciatori, Chiara Bazzichetto, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 2870-2870
Open Access | Times Cited: 102
Italia Falcone, Fabiana Conciatori, Chiara Bazzichetto, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 2870-2870
Open Access | Times Cited: 102